Nicholas Investment Partners, LP Bluebird Bio, Inc. Transaction History

Nicholas Investment Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $3.79 Million - $5.02 Million	-42,705 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $1.06 Million - $1.36 Million	10,629 Added 33.14%	42,705 $6.7 Million
Q1 2018 May 15, 2018	SELL	$105.8 - $150.94 $2.6 Million - $3.71 Million	-24,586 Reduced 43.39%	32,076 $5.48 Million
Q4 2017 Feb 14, 2018	SELL	$81.25 - $130.7 $1.19 Million - $1.92 Million	-14,667 Reduced 20.56%	56,662 $10.1 Million
Q3 2017 Nov 13, 2017	BUY	$57.74 - $91.42 $4.12 Million - $6.52 Million	71,329	71,329 $9.8 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $29.3M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.